ATP13A1 Peptide | 46-629P

ATP13A1 Peptide | 46-629P | Gentaur UK, US & Europe Distribution

Short Description: ATP13A1 Peptide

Species: Human

Location: ATP13A1 peptide corresponds to 13 amino acids of ATP13A1.

Tested Application: Bl

Application: ATP13A1 Peptide is used for blocking the activity of ATP13A1 antibody (catalog number 46-629). The ATP13A1 antibody ships at 0.5 mg/mL and the ATP13A1 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: ATP13A1 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: ATP13A1

Alternate Names: ATP13A, CGI-152, ATP13A, KIAA1825, Probable cation-transporting ATPase 13A1,

NCBI Gene ID: 57130

User Note: N/A

NCBI Official Name: Atpase Type 13A1

Background: N/A

Disclaimer: This product is for research use only.